Dayforce's 15min chart triggers Bollinger Bands expanding upward, KDJ golden cross.

According to the 15-minute chart for Dayforce, the Bollinger Bands are currently expanding upward, and a Golden Cross has occurred at the KDJ indicator, specifically at 08/27/2025 at 15:30. This suggests that the market trend is being driven by bullish sentiment, with the momentum of the stock price shifting towards the upside and potentially leading to further price appreciation.

Title: Dayforce Inc. (NYSE: DAY) Shows Bullish Sentiment with KDJ Golden Cross and Expanding Bollinger Bands

Dayforce Inc. (NYSE: DAY) has exhibited strong bullish sentiment in recent market movements, as indicated by its 15-minute chart analysis. According to National Research's 15-minute chart analysis, a KDJ Golden Cross and Bullish Marubozu signal was triggered on August 27, 2025, at 15:30 [1]. This technical indicator combination suggests a shift in momentum towards the upside, indicating potential further price increases. The dominance of buyers in the market is likely to continue, supporting a bullish trend.

Additionally, the Bollinger Bands are currently expanding upward, which further supports the bullish trend. Bollinger Bands are volatility indicators that consist of a simple moving average and two standard deviations above and below it. When the Bands widen, it indicates higher volatility and potential price movements. In this case, the upward expansion of the Bollinger Bands suggests that the market is expecting higher prices for Dayforce Inc. [1].

Technical analysis provides valuable insights into potential stock price movements, but it is crucial for investors to consider these signals in conjunction with fundamental analysis and broader market conditions. As of July 7, 2025, several notable companies have seen updates to their analyst ratings and price targets, reflecting the evolving opinions of financial experts. Positive Outlook: Alnylam Pharma (ALNY) received a "Buy" rating from Jefferies with a price target of $384.00 [1]. Chime Financial (CHYM) was initiated with an "Overweight" rating by multiple firms, including Morgan Stanley and Barclays, with targets ranging from $39.00 to $40.00 [1]. CryoPort (CYRX) was rated "Buy" by BTIG Research with a price target of $10.00 [1]. Datadog (DDOG) had its price target raised from $150.00 to $175.00 by Bank of America, reiterating a "Buy" rating [1]. Energy Transfer (ET) was initiated with a "Buy" rating by TD Cowen with a price target of $22.00 [1]. Grab (GRAB) was rated "Buy" by Jefferies with a price target of $5.70, indicating a 20.94% upside [1]. Home Depot (HD) was rated "Buy" by TD Cowen with a price target of $470.00 [1]. Intuit (INTU) was rated "Buy" by Morgan Stanley with a price target of $900.00 [1]. JPMorgan Chase & Co. (JPM) had a $298.00 target set by Evercore ISI with an "Outperform" rating [1]. Kinder Morgan (KMI) was initiated with a "Buy" rating by TD Cowen [1]. Lam Research (LRCX) had its "Buy" rating reiterated by Citigroup [1]. MACOM Technology Solutions (MTSI) had its target raised from $136.00 to $154.00 by Truist Financial, maintaining a "Buy" rating [1]. Monopar Therapeutics (MNPR) was initiated with an "Overweight" rating by Cantor Fitzgerald and a target of $74.00 [1]. Norwegian Cruise Line (NCLH) received a "Buy" rating from Jefferies with a price target of $29.00 [1]. Oracle (ORCL) received a "Buy" rating from UBS with a $250.00 target [1]. Oportun Financial (OPRT) was rated "Buy" at B. Riley Financial with an $11.00 price target [1]. Ovintiv (OVV) was rated "Buy" at Barclays Capital with a price target of $55.00 [1]. Phibro Animal Health (PAHC) was upgraded at JPMorgan Chase from Neutral to Overweight, with the price target raised from $25.00 to $35.00 [1]. Progressive (PGR) was downgraded by Morgan Stanley from Overweight to Equal Weight, with a price target of $290.00 [1]. Pulse Biosciences (PLSE) was initiated by Oppenheimer with an "Outperform" rating and a $22.00 price target [1]. PTC (PTC) had its Overweight rating reiterated by KeyCorp Bank [1]. Rockwell Automation (ROK) was initiated by CICC Research with a "Buy" rating and a price target of $320.00 [1].

References:
[1] https://www.ainvest.com/news/national-research-15min-chart-triggers-kdj-golden-cross-bullish-marubozu-formation-2508-63/